| Angiotensin II stimulation of NAD (P) H oxidase activity: upstream mediators PN Seshiah, DS Weber, P Rocic, L Valppu, Y Taniyama, KK Griendling Circulation research 91 (5), 406-413, 2002 | 966 | 2002 |
| The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration R Hutcheson, P Rocic Journal of Diabetes Research 2012 (1), 271028, 2012 | 287 | 2012 |
| NAD (P) H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling IR Hanna, Y Taniyama, K Szöcs, P Rocic, KK Griendling Antioxidants and Redox Signaling 4 (6), 899-914, 2002 | 243 | 2002 |
| Phosphoinositide-Dependent Kinase 1 and p21-Activated Protein Kinase Mediate Reactive Oxygen Species–Dependent Regulation of Platelet-Derived Growth Factor–Induced Smooth … DS Weber, Y Taniyama, P Rocic, PN Seshiah, MA Dechert, WT Gerthoffer, ... Circulation research 94 (9), 1219-1226, 2004 | 194 | 2004 |
| Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells Y Taniyama, M Ushio-Fukai, H Hitomi, P Rocic, MJ Kingsley, C Pfahnl, ... American Journal of Physiology-Cell Physiology 287 (2), C494-C499, 2004 | 177 | 2004 |
| Vascular endothelial growth factor is required for coronary collateral growth in the rat E Toyota, DC Warltier, T Brock, E Ritman, C Kolz, P O’Malley, P Rocic, ... Circulation 112 (14), 2108-2113, 2005 | 167 | 2005 |
| Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle DS Weber, P Rocic, AM Mellis, K Laude, AN Lyle, DG Harrison, ... American Journal of Physiology-Heart and Circulatory Physiology 288 (1), H37-H42, 2005 | 150 | 2005 |
| A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle P Rocic, G Govindarajan, A Sabri, PA Lucchesi American Journal of Physiology-Cell Physiology 280 (1), C90-C99, 2001 | 134 | 2001 |
| Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension A Alzoubi, M Toba, K Abe, KD O'Neill, P Rocic, KA Fagan, IF McMurtry, ... American Journal of Physiology-Heart and Circulatory Physiology, 2013 | 116 | 2013 |
| 20-HETE in the regulation of vascular and cardiac function P Rocic, ML Schwartzman Pharmacology & therapeutics 192, 74-87, 2018 | 108 | 2018 |
| Pyk2-and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions Y Taniyama, DS Weber, P Rocic, L Hilenski, ML Akers, J Park, ... Molecular and cellular biology, 2003 | 106 | 2003 |
| Redox-dependent mechanisms in coronary collateral growth: the “redox window” hypothesis J Yun, P Rocic, YF Pung, S Belmadani, ACR Carrao, V Ohanyan, ... Antioxidants & redox signaling 11 (8), 1961-1974, 2009 | 96 | 2009 |
| Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth P Rocic, C Kolz, R Reed, B Potter, WM Chilian American Journal of Physiology-Heart and Circulatory Physiology 292 (6 …, 2007 | 91 | 2007 |
| Role of MMP2 and MMP9 in TRPV4-induced lung injury PC Villalta, P Rocic, MI Townsley American Journal of Physiology-Lung Cellular and Molecular Physiology 307 (8 …, 2014 | 90 | 2014 |
| MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome R Hutcheson, R Terry, J Chaplin, E Smith, A Musiyenko, JC Russell, ... Arteriosclerosis, thrombosis, and vascular biology 33 (4), 727-736, 2013 | 82 | 2013 |
| Redox-dependent coronary metabolic dilation S Saitoh, T Kiyooka, P Rocic, PA Rogers, C Zhang, A Swafford, GM Dick, ... American Journal of Physiology-Heart and Circulatory Physiology 293 (6 …, 2007 | 78 | 2007 |
| Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats YF Pung, P Rocic, MP Murphy, RAJ Smith, J Hafemeister, V Ohanyan, ... Arteriosclerosis, thrombosis, and vascular biology 32 (2), 325-334, 2012 | 70 | 2012 |
| Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome? P Rocic Vascular pharmacology 57 (5-6), 179-186, 2012 | 65 | 2012 |
| The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth R Reed, C Kolz, B Potter, P Rocic Arteriosclerosis, thrombosis, and vascular biology 28 (1), 61-67, 2008 | 63 | 2008 |
| MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK T Dodd, R Jadhav, L Wiggins, J Stewart, E Smith, JC Russell, P Rocic Journal of Molecular and Cellular Cardiology 51 (6), 1015-1025, 2011 | 58 | 2011 |
